Home/HAGAR/Taire Rubin
TR

Taire Rubin

VP of Business Development

HAGAR

Therapeutic Areas

HAGAR Pipeline

DrugIndicationPhase
GWaveDiabetes mellitus (continuous glucose monitoring)Phase 2